| Literature DB >> 34287327 |
Riccardo L Alberio1, Mattia Rusconi2, Loris Martinetti2, Diego Monzeglio1, Federico A Grassi1,2.
Abstract
The purpose of this retrospective study is to compare the short-term clinical and radiological results between standard and dual mobility THA for femoral neck fractures (FNF) in older patients. The hypothesis is that the dual mobility cup (DMC) has the same outcomes but a lower dislocation rate than the standard THA. The study population included 56 patients (mean age 77.7 years, range 71-85) that underwent THA for displaced FNF. Patients were divided in two comparable groups for baseline characteristics (age, sex and comorbidities): 28 patients underwent THA with a standard cup (SC) and 28 THA with DMCs. The clinical records and radiograms were reviewed to search relevant data in their postoperative history. Two postoperative dislocations occurred in the SC group and none in the DMC group. At an average follow up of 23 months (12-40), 48 patients were available for the final evaluation. The WOMAC score for all patients averaged 6.26 (0-46) and was slightly better in the DMC group (4.94 vs. 7.58; p-value = 0.41); scores were significantly better in presence of neurological comorbidities (p-value = 0.04), in the absence of diabetes (p-value = 0.04) and in the case of psychiatric disorders (p-value = 0.02). Radiographic evaluation at one year showed signs of osteointegration in 42/48 (87.5%) acetabular components (20 DMCs, 22 SC). According to our experience, DMCs proved to be a valid option for the treatment of displaced FNF in older patients, since it allowed them to achieve short-term outcomes comparable to conventional THA, while decreasing the incidence of postoperative dislocations.Entities:
Keywords: dislocation; dual mobility cup; elderly patients; femoral neck fracture; total hip arthroplasty
Year: 2021 PMID: 34287327 PMCID: PMC8293229 DOI: 10.3390/geriatrics6030070
Source DB: PubMed Journal: Geriatrics (Basel) ISSN: 2308-3417
Demographic and relevant clinical data of the study population.
| DMC Group | SC Group | ||
|---|---|---|---|
| Age | 77.03 | 78.35 | 0.41 |
| Gender (M:F) | 7:21 | 7:21 | 1.00 |
| Neurological comorbidities (1) | 12 | 4 | 0.03 * |
| Diabetes | 0 | 3 | 0.23 |
| Obesity | 5 | 2 | 0.41 |
| Rheumatological diseases | 2 | 2 | 0.99 |
| Psychiatric disorders (2) | 6 | 0 | 0.02 * |
(1) Parkinson’s disease n = 3/1; Hemiplegia n = 1/0; Hemiparesis n =8/3. (2) Anxiety-depressive disorder n = 6/0. (*) statistically significant p-values.
Figure 1(a) Displaced intracapsular fracture (Garden-type IV) of the right femoral neck in a 79-year-old woman. (b) Postoperative radiograph after surgical treatment with a conventional THA. (c) Prosthesis dislocation 3 weeks after surgery. (d) Radiograph after implantation of a neck adaptor to increase length and lateral offset.
Figure 2(a) Postoperative radiograph of a DMC showing (arrows) a radiolucent line at the bone-implant interface. (b) Radiographic evidence of implant osteointegration one year after surgery.
Correlations between the WOMAC score and clinical-radiographic variables at follow up.
| Yes/No | Mean WOMAC | ||
|---|---|---|---|
| Neurological comorbidities | y 14 | 1.48 | 0.04 * |
| n 34 | 8.23 | ||
| Diabetes | y 3 | 17.0 | 0.04 * |
| n 45 | 5.55 | ||
| Obesity | y 7 | 1.56 | 0.23 |
| n 41 | 7.06 | ||
| Rheumatological diseases | y 4 | 1.25 | 0.32 |
| n 44 | 6.72 | ||
| Psychiatric disorders | y 6 | 0.00 | 0.02 * |
| n 42 | 7.16 | ||
| Dislocation | y 2 | 6.47 | 0.80 |
| n 46 | 1.5 | ||
| Osteointegration | y 37 | 4.96 | 0.16 |
| n 7 | 15.5 | ||
| Heterotopic ossifications | y 7 | 6.70 | 0.22 |
| n 41 | 6.19 |
WOMAC scores resulted to be significantly better in the presence of neurological comorbidities, in the absence of diabetes and in the case of psychiatric disorders. No statistical correlation could be found inside each group and in the comparison between the two groups because the sample size was too small. Better WOMAC scores, but without statistical significance, were found in the case of osteointegrated cups (p-value = 0.16). (*) statistically significant p-values.